scPharmaceuticals News

scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-J. Luther King, Jr.(5.8%),Luther King Capital Management Corporation(5.5%)

Nov 15 16:10 ET

scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Lundbeckfond Invest A/S (“Lundbeckfond”)(5.7%),Lene Skole (“Skole”)(5.7%)

Nov 14 17:51 ET

scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laurence W. Lytton(5.9%)

Nov 14 16:03 ET

scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-J. Luther King, Jr.(4.6%),Luther King Capital Management Corporation(4.5%)

Oct 30 16:07 ET

scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SCHAEFFER LEONARD D

Aug 28 16:33 ET

scPharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer Nokes Rachael

Aug 28 16:33 ET

scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner ORBIMED ADVISORS LLC

Aug 15 16:52 ET

scPharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Advisors LLC(12.1%),OrbiMed Capital GP VI LLC(11.6%), etc.

Aug 15 16:52 ET

scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nokes Rachael

Aug 8 16:22 ET

scPharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-J. Luther King, Jr.(6.4%),Luther King Capital Management Corporation(6.1%)

Jul 2 16:14 ET

scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Khattar Jack A.

Jun 13 17:05 ET

scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Hudson Frederick M.

Jun 13 17:05 ET

scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Agger Mette Kirstine

Jun 13 17:05 ET

scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director SCHAEFFER LEONARD D

Jun 13 17:05 ET

scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Abraham William Tober

Jun 13 17:04 ET

scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director VEITINGER KLAUS R DR

Jun 13 17:04 ET

scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Baylor-Henry Minnie

Jun 13 17:04 ET

scPharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Bonstein Sara

Jun 13 17:04 ET

scPharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-J. Luther King, Jr.(5.3%),Luther King Capital Management Corporation(5.0%)

May 20 16:14 ET

scPharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Laurence W. Lytton(5.1%)

Apr 29 14:39 ET